Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA.
There’s no risk. Start your trial today to see profiles of TriVascular Technologies (NASDAQ:TRIV) plus 5517 other startups.
Start Free 7 Day Trial Now